The Immunotherapy platform at MD Anderson brings together researchers and clinicians to develop innovative immunotherapeutic strategies against cancer. This initiative includes investigating immune checkpoint inhibitors, adoptive cell therapies like CAR-T cells, therapeutic vaccines, and other immunomodulatory approaches to enhance the body's immune response against cancer cells.